Catalyst Wire Dossier Catalyst Wire Dossier

Pyrrolitinib

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pyrrolitinib, covering 2021-02-03 to 2021-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Prevention and Treatment of Pyrrolitinib-associated Diarrhea [Phase 2, Phase 3]

See pricing